<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
IDXX
Idexx Laboratories
$
()


  • Idexx Laboratories price target raised by $75 at Piper Sandler, here's why

    2/8/2024 - 07:37am
  • Idexx Laboratories price target raised by $20 at Morgan Stanley, here's why

    2/6/2024 - 09:19am
  • Idexx Laboratories price target raised by $45 at Stifel, here's why

    2/6/2024 - 07:26am
  • Idexx Laboratories price target raised by $50 at Barclays, here's why

    2/6/2024 - 05:30am
  • Early notable gainers among liquid option names on February 5th

    2/5/2024 - 09:55am
  • Idexx Laboratories sees 2024 EPS $10.84-$11.33, consensus $11.00

    2/5/2024 - 06:34am
  • Idexx Laboratories reports Q4 EPS $2.32 with items, consensus $2.12

    2/5/2024 - 06:33am
  • Idexx Laboratories just downgraded at Piper Sandler, here's why

    1/30/2024 - 04:41am
  • Idexx Laboratories price target raised by $55 at BofA, here's why

    1/13/2024 - 10:02am
  • Idexx Laboratories price target raised by $85 at Stifel, here's why

    1/12/2024 - 14:18pm
  • Elanco just upgraded at Stifel, here's why

    1/5/2024 - 05:21am
  • Idexx Laboratories initiated with an Outperform at Exane BNP Paribas

    12/7/2023 - 05:33am
  • Idexx Laboratories upgraded to Buy from Neutral at Cleveland Research

    12/4/2023 - 10:52am
  • Early notable gainers among liquid option names on December 4th

    12/4/2023 - 09:55am
  • Idexx Laboratories narrows FY23 EPS view to $9.74-$9.90 from $9.64-$9.90

    11/1/2023 - 06:53am
dynamic_feed Breaking News